Central pharmacokinetics of levodopa: Lessons from imaging studies-Reference-Cited by-同舟云学术

Central pharmacokinetics of levodopa: Lessons from imaging studies

Published:2014-10-01 Issue:1 Volume:30 Page:73-79
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Stoessl A. Jon¹

Affiliation:

1. Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health; University of British Columbia & Vancouver Coastal Health; 2221 Wesbrook Mall Vancouver BC CANADA V6T 2B5

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference35 articles.

1. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease;Lee;Ann Neurol,2000

2. Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease;Nandhagopal;Brain,2011

3. Human positron emission tomographic [18 F]fluorodopa studies correlate with dopamine cell counts and levels;Snow;Ann Neurol,1993

4. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias;Colloby;Brain,2012

5. Novel observations with FDOPA-PET imaging after early nigrostriatal damage;Yee;Mov Disord,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Continuous Dopaminergic Therapies in Parkinson’s Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics;Journal of Parkinson's Disease;2024-07-23

2. Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions;Journal of Clinical Medicine;2023-06-30

3. Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation;Clinical Parkinsonism & Related Disorders;2023

4. Changing Gears – DBS For Dopaminergic Desensitization in Parkinson's Disease?;Annals of Neurology;2021-07-20

5. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease;Brain;2021-05-12